Source Natural Foods & Herbal Supplements Ltd

Source Natural has demonstrated significant growth in net sales and profitability, with net sales increasing from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, and profit after tax rising from 2.12 Cr to 2.90 Cr during the same period. The company's total assets also grew from 21.45 Cr to 35.83 Cr, indicating a positive trend in financial performance.

Source Natural has shown significant growth in net sales, increasing from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, alongside rising profitability, with profit after tax growing from 2.12 Cr to 2.90 Cr during the same period, despite increased expenditures. Total assets also rose from 21.45 Cr to 35.83 Cr, indicating a strong overall financial performance.

Source Natural has shown significant growth in net sales and profitability, with net sales increasing from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, and profit after tax rising from 2.12 Cr to 2.90 Cr in the same period, reflecting strong financial performance and stability.

As of November 13, 2025, Source Natural is fairly valued with a PE ratio of 29.30 and a PEG ratio of 0.46, indicating reasonable valuation compared to peers, despite a 41.67% decline in stock performance over the past year.

Source Natural has shown significant growth in net sales, increasing from 19.77 crore in March 2023 to 44.92 crore in March 2025, with a profit after tax of 2.90 crore. The company has maintained a strong upward trend in profitability and total assets, despite fluctuations in profit margins.

The next results date for Source Natural is 14 November 2025.

As of 10-Nov, Source Natural Foods & Herbal Supplements Ltd is facing a decline in stock price to Rs 140.00, down 2.54%, and has underperformed its sector significantly. The stock is trading below all major moving averages and has seen a drastic drop in investor participation, with a year-to-date decline of 27.46% compared to the Sensex's rise of 6.91%.

As of November 7, 2025, Source Natural's valuation has shifted from attractive to fair, with a PE ratio of 29.64, a Price to Book Value of 4.14, and an EV to EBITDA ratio of 16.78, indicating moderate value compared to peers, despite a significant stock underperformance of -41.04% over the past year.

As of November 7, 2025, Source Natural is fairly valued with a PE ratio of 29.64, lower than some peers like Sun Pharma and Divi's Lab, but higher than Cipla, and has underperformed the Sensex with a return of -41.04% over the past year.

As of November 7, 2025, Source Natural is fairly valued with a PE ratio of 29.64, lower than some peers but higher than others, and has underperformed the Sensex by 41.04% over the past year, indicating potential for recovery despite not being a bargain.

As of October 31, 2025, Source Natural is considered undervalued with an attractive valuation grade, featuring a PE ratio of 29.87, an EV to EBITDA of 16.92, and a PEG ratio of 0.47, which are favorable compared to its peers, despite a year-to-date return of -24.97% against the Sensex's 7.42%.

As of October 31, 2025, Source Natural is considered undervalued with an attractive valuation grade, highlighted by a PE Ratio of 29.87 and a PEG Ratio of 0.47, indicating strong growth potential compared to peers like Sun Pharma and Divi's Lab, despite a year-to-date return of -24.97% against the Sensex's 7.42%.

As of October 31, 2025, Source Natural is considered an attractive investment due to its undervalued financial metrics, including a PE ratio of 29.87 and a PEG ratio of 0.47, which are significantly lower than its peers, despite a year-to-date stock performance lagging behind the Sensex.

As of October 30, 2025, Source Natural's valuation has shifted from attractive to fair, with a PE ratio of 32.08, an EV to EBITDA ratio of 18.17, and a ROCE of 19.92%, positioning it in the middle of its peers despite a year-to-date stock decline of 19.43%.

As of 28-Oct, Source Natural Foods & Herbal Supplements Ltd's stock price is 148.90, down 0.47%, with a significant drop in investor participation and a year-to-date decline of 22.85%. Despite recent gains, its performance lags behind the broader market, indicating mixed momentum signals.

As of 20-October, Source Natural Foods & Herbal Supplements Ltd is currently priced at 153.95, reflecting an 11.3 increase and a 7.92% rise. Despite recent gains, the stock has a year-to-date decline of 20.23% and a one-year decline of 40.62%, indicating ongoing long-term challenges.